What role does FTO play in Blutzucker?

The provided context does not include specific information on FTO. Based on established knowledge, FTO (fat mass and obesity-associated) gene variants, particularly rs9939609, are strongly associated with increased body mass index and a modestly elevated risk of type 2 diabetes in large GWAS. The effect on blood glucose is indirect, mediated through appetite regulation, energy expenditure, and adiposity. Carriers of the risk allele tend to have slightly higher fasting glucose and lower insulin sensitivity, but the effect size is small and modifiable by lifestyle. The molecular mechanism is not fully understood; FTO acts as a demethylase affecting N6-methyladenosine RNA modification, influencing gene expression in the hypothalamus and adipose tissue. Importantly, FTO is not a monogenic diabetes gene but a polygenic risk factor. A genetic test alone cannot predict individual blood sugar trajectories. Evidence is strong for association (GWAS) but limited for direct causality. For elevated blood sugar, established risk factors such as weight, diet, and physical activity should be prioritized.